UPOINT System: A Diagnostic/Therapeutic Algorithm for Chronic Prostatitis/Chronic Pelvic Pain Syndrome

다국어 초록 (Multilingual Abstract)

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common condition that significantly affects the quality of life. On the other hand, urologists find it challenging to treat this disorder effectively. To date, the Urinary, Psychosocial, Organ-Specific, Infection, Neurological/Systemic, and Tenderness (UPOINT) system is the only classification tool that can improve the treatment outcomes significantly compared to monotherapy. This review focused on the most recent advances in the diagnosis and treatment of CP/CPPS.

참고문헌 (Reference)

1 Magri V, "Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts : sexual function domain improves correlations" 184 : 2339-2345, 2010

2 Nickel JC, "Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin : a randomized double blind trial" 171 : 1594-1597, 2004

3 Falahatkar S, "Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome : results of a prospective pilot double-blind and randomized placebo-controlled study" 116 : 641-649, 2015

4 Li HS, "Transperineal ultrasonic therapy for chronic prostatitis" 19 : 49-53, 2013

5 공도훈, "The Efficacy of Mirodenafil for Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Middle-Aged Males" 대한남성과학회 32 (32): 145-150, 2014

6 Allsop SA, "The DABBEC phenotyping system : towards a mechanistic understanding of CP/CPPS" 8 : 107-113, 2011

7 Nickel JC, "Tanezumab reduces pain in women with interstitial cystitis/bladder pain syndrome and patients with nonurological associated somatic syndromes" 195 (195): 942-948, 2016

8 Qin Z, "Systematic review of acupuncture for chronic prostatitis/chronic pelvic pain syndrome" 95 : e3095-, 2016

9 Kessler TM, "Sono-electro-magnetic therapy for treating chronic pelvic pain syndrome in men : a randomized, placebocontrolled, double-blind trial" 9 : e113368-, 2014

10 Nickel JC, "Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study" 186 : 125-131, 2011

11 Sandhu J, "Recent advances in managing chronic prostatitis/chronic pelvic pain syndrome" 6 : 2017

12 Krieger JN, "NIH consensus definition and classification of prostatitis" 282 : 236-237, 1999

13 Magri V, "Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients" 9 : 658-666, 2015

14 du Plessis SS, "Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility" 32 : 1575-1588, 2015

15 Smith CP, "Male chronic pelvic pain : an update" 32 : 34-39, 2016

16 Davis SN, "Is a sexual dysfunction domain important for quality of life in men with urological chronic pelvic pain syndrome? Signs"UPOINT"to yes" 189 : 146-151, 2013

17 Samplaski MK, "Inclusion of erectile domain to UPOINT phenotype does not improve correlation with symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome" 78 : 653-658, 2011

18 Wagenlehner FM, "Immunostimulation in chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS) : a one-year prospective, double-blind, placebo-controlled study" 32 : 1595-1603, 2014

19 Hedelin HH, "Evaluation of a modification of the UPOINT clinical phenotype system for the chronic pelvic pain syndrome" 43 : 373-376, 2009

20 Zhou Z, "Detection of nanobacteria infection in type III prostatitis" 71 : 1091-1095, 2008

21 Magistro G, "Contemporary management of chronic prostatitis/chronic pelvic pain syndrome" 69 : 286-297, 2016

22 Kartha GK, "Clinical phenotyping of urologic pain patients" 23 : 560-564, 2013

23 Shoskes DA, "Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis : a management strategy for urologic chronic pelvic pain syndromes" 12 : 177-183, 2009

24 Shoskes DA, "Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system" 31 : 755-760, 2013

25 Kotb AF, "Chronic prostatitis/chronic pelvic pain syndrome : the role of an antifungal regimen" 66 : 196-199, 2013

26 Polackwich AS, "Chronic prostatitis/chronic pelvic pain syndrome : a review of evaluation and therapy" 19 : 132-138, 2016

27 Zhao WP, "Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome(Category IIIA)" 42 : 963-967, 2009

28 Gundersen TD, "Association between use of marijuana and male reproductive hormones and semen quality : a study among 1, 215 healthy young men" 182 : 473-481, 2015

29 Bozzini G, "An observational study of the use of beclomethasone dipropionate suppositories in the treatment of lower urinary tract inflammation in men" 16 : 25-, 2016

30 Blanchet KD, "Acupuncture : gaining acceptance in urology : proves effective for a number of chronic conditions" 109 : 2-4, 2012

31 Tripp DA, "A survey of cannabis(marijuana)use and self-reported benefit in men with chronic prostatitis/chronic pelvic pain syndrome" 8 : E901-E905, 2014

32 Davis SN, "A subtype based analysis of urological chronic pelvic pain syndrome in men" 190 : 118-123, 2013